CURRENT
ISSUE1616
January 25, 2021
On December 18, 2020, the FDA issued an Emergency
Use Authorization (EUA) for the Moderna mRNA-based
vaccine for prevention of COVID-19 in persons
≥18 years old. The Pfizer-BioNTech mRNA-based
vaccine received an FDA EUA for the same indication
in persons ≥16 years old on December 11,... read more...
More from issue 1616
Coming Soon
Twirla - A New Contraceptive Patch
Pitolisant (Wakix) for Excessive Daytime Sleepiness
Osilodrostat (Isturisa) for Cushing’s Disease
Sacituzumab Govitecan (Trodelvy) for Metastatic Triple-Negative Breast Cancer
Drugs for Parkinson's Disease
Recommend to Your Library
Previous Issues
January 11, 2021 (1615)
- FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine
- Baloxavir (Xofluza) for Post-Exposure Prophylaxis of Influenza
- Opicapone (Ongentys) - A COMT Inhibitor for Parkinson's Disease
- Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis
- In Brief: An Asenapine Patch (Secuado) for Schizophrenia
December 28, 2020 (1614)
- An EUA for Casirivimab and Imdevimab for COVID-19
- An EUA for Baricitinib (Olumiant) for COVID-19
- Ofatumumab (Kesimpta) for Multiple Sclerosis
- IV Amisulpride (Barhemsys) for Postoperative Nausea and Vomiting
- Pemigatinib (Pemazyre) for Cholangiocarcinoma (online only)
- 2020 Annual Index (Online Only)
December 14, 2020 (1613)
- Drugs for Asthma
- Some Inhaled Drugs for Treatment of Asthma (online only)
- Correct Use of Inhalers for Asthma (online only)
November 30, 2020 (1612)
- An EUA for Bamlanivimab - A Monoclonal Antibody for COVID-19
- Remdesivir (Veklury) for COVID-19
- Drugs for Acne
- In Brief: New Meningococcal Serogroup B Vaccination Recommendations
November 16, 2020 (1611)
